KetoSwiss

About KetoSwiss

KetoSwiss is a Swiss-based biotech startup that develops ketone body supplements to provide an alternative energy source for individuals with metabolic disorders. Their product, MigraKet, specifically targets migraine management by utilizing the neuroprotective properties of ketones to alleviate symptoms.

```xml <problem> Individuals with metabolic disorders often lack efficient energy production pathways, leading to fatigue and other complications. Migraine sufferers experience debilitating headaches and neurological symptoms that significantly impact their quality of life. </problem> <solution> KetoSwiss develops ketone body supplements designed to provide an alternative energy source, particularly for individuals with metabolic disorders and migraine sufferers. Their flagship product, MigraKet, leverages the neuroprotective properties of ketones to potentially alleviate migraine symptoms. By providing an alternative fuel source for the brain, MigraKet aims to reduce the frequency and severity of migraine attacks. The supplement is now available for purchase in the US, with plans for international expansion. </solution> <features> - Utilizes ketone bodies as an alternative energy source for the brain. - Designed to potentially reduce migraine frequency and severity. - Aims to provide neuroprotective benefits through ketone supplementation. - Currently available for purchase in the US. </features> <target_audience> The primary target audience includes individuals with metabolic disorders seeking alternative energy sources and migraine sufferers looking for ways to manage their symptoms. </target_audience> ```

What does KetoSwiss do?

KetoSwiss is a Swiss-based biotech startup that develops ketone body supplements to provide an alternative energy source for individuals with metabolic disorders. Their product, MigraKet, specifically targets migraine management by utilizing the neuroprotective properties of ketones to alleviate symptoms.

Where is KetoSwiss located?

KetoSwiss is based in Basel, Switzerland.

When was KetoSwiss founded?

KetoSwiss was founded in 2017.

How much funding has KetoSwiss raised?

KetoSwiss has raised 10450000.

Location
Basel, Switzerland
Founded
2017
Funding
10450000
Employees
8 employees
Major Investors
The William K. Warren Foundation

Find Investable Startups and Competitors

Search thousands of startups using natural language

Start Searching

KetoSwiss

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

KetoSwiss is a Swiss-based biotech startup that develops ketone body supplements to provide an alternative energy source for individuals with metabolic disorders. Their product, MigraKet, specifically targets migraine management by utilizing the neuroprotective properties of ketones to alleviate symptoms.

keto.swiss2K+
cb
Crunchbase
Founded 2017 – Basel, Switzerland

Funding

$

Estimated Funding

$10M+

Major Investors

The William K. Warren Foundation

Team (5+)

No team information available.

Company Description

Problem

Individuals with metabolic disorders often lack efficient energy production pathways, leading to fatigue and other complications. Migraine sufferers experience debilitating headaches and neurological symptoms that significantly impact their quality of life.

Solution

KetoSwiss develops ketone body supplements designed to provide an alternative energy source, particularly for individuals with metabolic disorders and migraine sufferers. Their flagship product, MigraKet, leverages the neuroprotective properties of ketones to potentially alleviate migraine symptoms. By providing an alternative fuel source for the brain, MigraKet aims to reduce the frequency and severity of migraine attacks. The supplement is now available for purchase in the US, with plans for international expansion.

Features

Utilizes ketone bodies as an alternative energy source for the brain.

Designed to potentially reduce migraine frequency and severity.

Aims to provide neuroprotective benefits through ketone supplementation.

Currently available for purchase in the US.

Target Audience

The primary target audience includes individuals with metabolic disorders seeking alternative energy sources and migraine sufferers looking for ways to manage their symptoms.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.